These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 222145

  • 1. A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
    Dujovne CA, Azarnoff DL, Pentikainen P, Manion CV, Hurwitz A.
    Am J Med Sci; 1979; 277(3):255-61. PubMed ID: 222145
    [Abstract] [Full Text] [Related]

  • 2. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R, Müller A, Klose G, Middelhoff G, Augustin J, Haase W, Greten H.
    MMW Munch Med Wochenschr; 1978 Apr 14; 120(15):525-8. PubMed ID: 206826
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the lipid-lowering effect of clofibrate, and of clofibrate plus beta-pyridylcarbinol.
    Graham L, Mulcahy R, Hickey N.
    Atherosclerosis; 1977 Aug 14; 27(4):487-92. PubMed ID: 884003
    [Abstract] [Full Text] [Related]

  • 4. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
    Carlson LA, Olsson G, Ballantyne D.
    Atherosclerosis; 1977 Apr 14; 26(4):603-9. PubMed ID: 193526
    [Abstract] [Full Text] [Related]

  • 5. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P, Schwandt P.
    Klin Wochenschr; 1977 Aug 15; 55(16):791-4. PubMed ID: 198601
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
    Wolfram G, Keller C, Kilani S, Zöllner N.
    Dtsch Med Wochenschr; 1976 Jan 16; 101(3):76-81. PubMed ID: 1245160
    [Abstract] [Full Text] [Related]

  • 7. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA, Grundy SM.
    JAMA; 1984 May 04; 251(17):2241-6. PubMed ID: 6368883
    [Abstract] [Full Text] [Related]

  • 8. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR, Yeshurun D, Jackson RL, Gotto AM.
    Am J Med; 1977 Dec 04; 63(6):1001-9. PubMed ID: 204188
    [No Abstract] [Full Text] [Related]

  • 9. A two-year crossover therapeutic trial with halofenate and clofibrate.
    Dujovne CA, Azarnoff DL, Pentikainen P, Manion C, Hurwitz A, Hassanein K.
    Am J Med Sci; 1976 Dec 04; 272(3):277-84. PubMed ID: 797258
    [Abstract] [Full Text] [Related]

  • 10. Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate.
    Lehtonen A, Viikari J.
    Atherosclerosis; 1979 May 04; 33(1):49-58. PubMed ID: 223601
    [Abstract] [Full Text] [Related]

  • 11. Clofibrate and tiadenol treatment in hyperlipoproteinemias. A comparative trial of drugs affecting lipoprotein catabolism and biosynthesis.
    Sirtori M, Montanari G, Gianfranceschi G, Malacrida MG, Battistin P, Morazzoni G, Tremoli E, Colli S, Maderna P, Sirtori CR.
    Atherosclerosis; 1983 Nov 04; 49(2):149-61. PubMed ID: 6365105
    [Abstract] [Full Text] [Related]

  • 12. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Nov 04; 33(12):1682-4. PubMed ID: 6686774
    [Abstract] [Full Text] [Related]

  • 13. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
    Brook JG, Lavy A, Aviram M, Zinder O.
    Atherosclerosis; 1980 Aug 04; 36(4):461-9. PubMed ID: 7417365
    [Abstract] [Full Text] [Related]

  • 14. One-year trials with halofenate, clofibrate, and placebo.
    Dujovne CA, Azarnoff DL, Huffman DH, Pentikäinen P, Hurwitz A, Shoeman DW.
    Clin Pharmacol Ther; 1976 Mar 04; 19(3):352-9. PubMed ID: 177242
    [Abstract] [Full Text] [Related]

  • 15. [The treatment of hypertriglyceridemia].
    Wollenweber J.
    ZFA (Stuttgart); 1978 Feb 28; 54(6):349-53. PubMed ID: 636529
    [No Abstract] [Full Text] [Related]

  • 16. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB, Probstfield JL, Crow LO, Isaacson SO.
    Metabolism; 1981 Jun 28; 30(6):605-9. PubMed ID: 7231197
    [Abstract] [Full Text] [Related]

  • 17. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB, Bell C, Olson L.
    Metabolism; 1981 Jun 28; 30(6):610-5. PubMed ID: 7231198
    [Abstract] [Full Text] [Related]

  • 18. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
    Olsson AG, Lang PD.
    Atherosclerosis; 1978 Dec 28; 31(4):429-33. PubMed ID: 215175
    [Abstract] [Full Text] [Related]

  • 19. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE, Lees RS.
    J Clin Invest; 1972 May 28; 51(5):1051-7. PubMed ID: 4341500
    [Abstract] [Full Text] [Related]

  • 20. [Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
    Schwartzkopff W, Zschiedrich M.
    Med Klin; 1978 Feb 17; 73(7):231-9. PubMed ID: 203832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.